Monograph Capital is a venture capital firm that focuses on funding innovative life sciences companies, aiming to translate promising scientific discoveries into life-changing treatments globally. Their strategy involves leveraging deep medical expertise, extensive pharmaceutical relationships, and seasoned operational experience to build value for their partners and investors.
Portfolio
1
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
 Ascend Gene & Cell Therapies | Series A | $132.5M | May 2023 |
Top Co-Investors
Last updated: 4 March 2026